Publication | Closed Access

A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned

ThrombosisCardiovascular DiseaseMyocardial InfarctionPatient SafetyCardiovascular PharmacologyArrhythmiaPharmacotherapyRandomized TrialAcute Myocardial InfarctionAtrial FibrillationPublic HealthDirect Current CardioversionMedicineCardiologyEmergency MedicineAnesthesiologyCardiac Arrest